Glaukos Corp (GKOS)
107.62
+0.71
(+0.66%)
USD |
NYSE |
May 09, 16:00
107.66
+0.04
(+0.04%)
Pre-Market: 20:00
Glaukos Debt to Equity Ratio: 0.6281 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.6281 |
December 31, 2023 | 0.6124 |
September 30, 2023 | 0.5913 |
June 30, 2023 | 0.5771 |
March 31, 2023 | 0.5541 |
December 31, 2022 | 0.5309 |
September 30, 2022 | 0.5124 |
June 30, 2022 | 0.4991 |
March 31, 2022 | 0.4692 |
December 31, 2021 | 0.4769 |
September 30, 2021 | 0.4653 |
June 30, 2021 | 0.4781 |
March 31, 2021 | 0.4731 |
December 31, 2020 | 0.2838 |
September 30, 2020 | 0.2822 |
June 30, 2020 | 0.2778 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
Date | Value |
---|---|
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.0276 |
June 30, 2016 | 0.0503 |
March 31, 2016 | 0.0765 |
December 31, 2015 | 0.1019 |
September 30, 2015 | 0.1251 |
June 30, 2015 | 0.2208 |
March 31, 2015 | 3.642 |
December 31, 2014 | -0.1279 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.6281
Maximum
Mar 2024
0.3856
Average
0.475
Median
Debt to Equity Ratio Benchmarks
Boston Scientific Corp | 0.5327 |
Globus Medical Inc | 0.1081 |
PROCEPT BioRobotics Corp | 0.1946 |
Accuray Inc | 4.223 |
Asensus Surgical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 933.34M |
Total Liabilities (Quarterly) | 482.61M |
Shareholders Equity (Quarterly) | 450.73M |
Current Ratio | 5.380 |
Net Debt Paydown Yield | -0.01% |